Starting...

Date:
[1] "2023-04-28"


Time:
[1] "2023-04-28 16:00:56 BST"



R session info:

R version 4.1.2 (2021-11-01)
Platform: x86_64-apple-darwin17.0 (64-bit)
Running under: macOS Big Sur 10.16

Matrix products: default
BLAS:   /Library/Frameworks/R.framework/Versions/4.1/Resources/lib/libRblas.0.dylib
LAPACK: /Library/Frameworks/R.framework/Versions/4.1/Resources/lib/libRlapack.dylib

locale:
[1] en_GB.UTF-8/en_GB.UTF-8/en_GB.UTF-8/C/en_GB.UTF-8/en_GB.UTF-8

attached base packages:
[1] stats     graphics  grDevices utils     datasets  methods   base     

other attached packages:
[1] readxl_1.4.1       lme4_1.1-30        Matrix_1.5-1       matrixStats_0.63.0

loaded via a namespace (and not attached):
 [1] minqa_1.2.4      MASS_7.3-58.1    compiler_4.1.2   Rcpp_1.0.10      cellranger_1.1.0
 [6] splines_4.1.2    nlme_3.1-160     grid_4.1.2       nloptr_2.0.3     boot_1.3-28     
[11] lattice_0.20-45 



Loaded data

Completed initial data processing

General data summary

Total number of participants in data: 82
Total number of participants in treatment-as-usual: 42
Total number of participants in MUSE treatment group 40

Total number of participants at site 1: 39
Total number of participants at site 2: 43

Total number of participants with PSYRATS-voices total data at baseline: 82
Total number of participants with PSYRATS-voices total data at 8 weeks: 72
Total number of participants with PSYRATS-voices total data at 12 weeks: 71



Table of baseline values values across groups; format `n male/n all` for sex, median (IQR) for N_sessions_muse, `mean (SD) m. missing%` otherwise: 

                                all            TAU                     MUSE                  
Age                             30.4 (10.34)   29.21 (10.27)           31.65 (10.4)          
Sex_male                        44/82; m. 1%   22/42; m. 2%            22/40                 
Baseline_hallucination_duration NA             70.32 (103.6); m. 12%   102.1 (117.4); m. 5%  
Time_engaged_in_service         10.54 (9.501)  10.57 (9.988)           10.5 (9.089)          
N_sessions_muse                 NA             NA                      NA                    
                                site1_all              site1_TAU              
Age                             33.08 (10.67)          32.25 (12.04)          
Sex_male                        23/39                  10/20                  
Baseline_hallucination_duration 80.81 (132.9); m. 8%   79.33 (132.3); m. 10%  
Time_engaged_in_service         10.46 (9.205)          10.2 (10.5)            
N_sessions_muse                 NA                     NA                     
                                site1_MUSE             site2_all             
Age                             33.95 (9.27)           27.98 (9.511)         
Sex_male                        13/19                  21/43; m. 2%          
Baseline_hallucination_duration 82.28 (137.3); m. 5%   91.64 (88.21); m. 9%  
Time_engaged_in_service         10.74 (7.894)          10.6 (9.871)          
N_sessions_muse                 6 (1); m. 11%          NA                    
                                site2_TAU               site2_MUSE          
Age                             26.45 (7.608)           29.57 (11.13)       
Sex_male                        12/22; m. 5%            9/21                
Baseline_hallucination_duration 61.79 (69.26); m. 14%   120 (96.33); m. 5%  
Time_engaged_in_service         10.91 (9.734)           10.29 (10.24)       
N_sessions_muse                 NA                      5 (1); m. 19%       

Table saved in: ./Analysis/Results/Tables/baseline_data.csv


Table of summary values across groups; format `mean (SD) m. missing%`: 

                                 variable_type all                     TAU                    
baseline_psyrats_total           real          43.52 (9.963)           43.26 (9.9)            
8week_psyrats_total              real          35 (17.04); m. 12%      35.03 (18.5); m. 14%   
12week_psyrats_total             real          31.06 (16.13); m. 13%   31.58 (16.48); m. 14%  
baseline_psyrats_voices_total    real          29.56 (4.994)           29.81 (4.452)          
8week_psyrats_voices_total       real          24.04 (11.55); m. 12%   23.53 (12.89); m. 14%  
12week_psyrats_voices_total      real          22.15 (11.77); m. 13%   22.39 (11.65); m. 14%  
baseline_psyrats_delusions_total real          13.96 (7.178)           13.45 (7.369)          
8week_psyrats_delusions_total    real          10.96 (8.529); m. 12%   11.5 (8.749); m. 14%   
12week_psyrats_delusions_total   real          8.901 (8.094); m. 13%   9.194 (8.318); m. 14%  
                                 MUSE                    site1_all             
baseline_psyrats_total           43.8 (10.15)            43.79 (10.88)         
8week_psyrats_total              34.97 (15.7); m. 10%    29.92 (18.66); m. 5%  
12week_psyrats_total             30.51 (15.99); m. 12%   26.27 (16.82); m. 5%  
baseline_psyrats_voices_total    29.3 (5.553)            30.21 (5.606)         
8week_psyrats_voices_total       24.56 (10.2); m. 10%    21.81 (13.21); m. 5%  
12week_psyrats_voices_total      21.91 (12.05); m. 12%   20.78 (13.58); m. 5%  
baseline_psyrats_delusions_total 14.5 (7.024)            13.59 (7.697)         
8week_psyrats_delusions_total    10.42 (8.392); m. 10%   8.108 (8.928); m. 5%  
12week_psyrats_delusions_total   8.6 (7.968); m. 12%     5.486 (7.578); m. 5%  
                                 site1_TAU              site1_MUSE            
baseline_psyrats_total           44 (10.43)             43.58 (11.63)         
8week_psyrats_total              29.95 (18.9); m. 5%    29.89 (18.95); m. 5%  
12week_psyrats_total             25.79 (15.83); m. 5%   26.78 (18.25); m. 5%  
baseline_psyrats_voices_total    30.55 (4.501)          29.84 (6.685)         
8week_psyrats_voices_total       20.84 (13.88); m. 5%   22.83 (12.78); m. 5%  
12week_psyrats_voices_total      20.63 (12.4); m. 5%    20.94 (15.09); m. 5%  
baseline_psyrats_delusions_total 13.45 (7.494)          13.74 (8.109)         
8week_psyrats_delusions_total    9.105 (9.362); m. 5%   7.056 (8.585); m. 5%  
12week_psyrats_delusions_total   5.158 (7.388); m. 5%   5.833 (7.972); m. 5%  
                                 site2_all               site2_TAU              
baseline_psyrats_total           43.28 (9.171)           42.59 (9.59)           
8week_psyrats_total              40.37 (13.41); m. 19%   40.71 (16.79); m. 23%  
12week_psyrats_total             36.26 (13.78); m. 21%   38.06 (15.1); m. 23%   
baseline_psyrats_voices_total    28.98 (4.351)           29.14 (4.4)            
8week_psyrats_voices_total       26.4 (9.098); m. 19%    26.53 (11.33); m. 23%  
12week_psyrats_voices_total      23.65 (9.384); m. 21%   24.35 (10.78); m. 23%  
baseline_psyrats_delusions_total 14.3 (6.745)            13.45 (7.43)           
8week_psyrats_delusions_total    13.97 (7.023); m. 19%   14.18 (7.376); m. 23%  
12week_psyrats_delusions_total   12.62 (7.002); m. 21%   13.71 (6.998); m. 23%  
                                 site2_MUSE             
baseline_psyrats_total           44 (8.888)             
8week_psyrats_total              40.06 (9.686); m. 14%  
12week_psyrats_total             34.47 (12.52); m. 19%  
baseline_psyrats_voices_total    28.81 (4.4)            
8week_psyrats_voices_total       26.28 (6.685); m. 14%  
12week_psyrats_voices_total      22.94 (8.019); m. 19%  
baseline_psyrats_delusions_total 15.19 (5.997)          
8week_psyrats_delusions_total    13.78 (6.882); m. 14%  
12week_psyrats_delusions_total   11.53 (7.046); m. 19%  

Full table saved in: ./Analysis/Results/Tables/general_table.csv




***********************************************
** 10.2.1: Mixed linear model analysis PPO   **
**  No covariates included other than site   **
***********************************************


Estimated beta_2 (mean effect of treatment on PSYRATS voices total score at 8 weeks) 1.631 points;  95% CI: (-2.002, 5.256) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       7.30800      5.919      8.766                SD of per-indivudal random effect
σe       6.32100      5.589      7.025                                  SD of residuals
β0      28.64000     25.840     31.450                                     Overall mean
βa2     -6.39300     -9.105     -3.673               Fixed effect for 8-week time point
βa3     -7.27800     -9.991     -4.560              Fixed effect for 12-week time point
β(site)  1.74800     -1.847      5.337                Fixed effect for site 2 vs site 1
β2       1.63100     -2.002      5.256  Fixed effect for treatment at 8-week time point
β3      -0.05288     -3.707      3.594 Fixed effect for treatment at 12-week time point


Parameter table saved to: ./Analysis/Results/Tables/PSYRATs_voices_total/parameter_table_psyrats_voices_total.csv




***********************************************
** 10.2.1b: Mixed linear model analysis PPO  **
**  No covariates included other than site   **
**  Sample size calculation (empirical)      **
***********************************************


To have 90% power to detect an effect of MUSE of 1.631 points on PSYRATS-voices total, with other parameters as estimated, we need a minimum of 481 samples per arm




***********************************************
** 10.2.2: Mixed linear model analysis PPO   **
**  Covariates included                      **
***********************************************


Estimated beta_2 (mean effect of treatment on PSYRATS voices total score at 8 weeks) including covariates in linear mixed model: 0.2546 points;  95% CI: (-3.357, 3.787) points

All parameter estimates and 95% CIs, including covariates: 

              Estimate CI95_lower CI95_upper
σr            6.428000    4.75400    7.44400
σe            6.040000    5.30200    6.73800
β0           16.510000    8.22700   24.77000
βa2          -5.283000   -7.99100   -2.52900
βa3          -7.173000   -9.88800   -4.43500
β(site)       0.267000   -3.34300    3.88200
β(age)        0.119300   -0.05296    0.29160
β(sex_M)     -1.989000   -5.40900    1.43000
β(mod_total)  1.902000   -0.11360    3.91900
β(base_dur)   0.003215   -0.01291    0.01935
β(time_eng)   0.087200   -0.08553    0.26020
β(delusions)  0.344000    0.08156    0.60730
β2            0.254600   -3.35700    3.78700
β3            0.029730   -3.58700    3.59200
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point


Parameter table saved to: ./Analysis/Results/Tables/PSYRATs_voices_total/parameter_table_psyrats_voices_total_covariates.csv




***********************************************
** 10.2.3: Within-treatment analysis of      **
**  number of treatments                     **
***********************************************


Estimated beta_2 (mean effect of number of MUSE treatments on PSYRATS voices total score at 8 weeks; incremental effect of one additional treament) 0.8104 points;  95% CI: (-1.426, 3.041) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper
σr        7.9500      5.807     10.300
σe        5.8410      4.835      6.789
β0       27.9700     23.610     32.330
βa2      -9.0150    -21.260      3.267
βa3      -5.7870    -18.080      6.533
β(site)   1.6980     -4.081      7.481
β2        0.8104     -1.426      3.041
β3       -0.3003     -2.539      1.933
                                                                  Description
σr                                          SD of per-indivudal random effect
σe                                                            SD of residuals
β0                                                               Overall mean
βa2                                        Fixed effect for 8-week time point
βa3                                       Fixed effect for 12-week time point
β(site)                                     Fixed effect for site 2 vs site 1
β2                 Fixed effect for number of treatments at 8-week time point
β3      Fixed effect for number of treatments treatment at 12-week time point


Parameter table saved to: ./Analysis/Results/Tables/PSYRATs_voices_total/parameter_table_n_treatments_psyrats_voices_total.csv




***********************************************
** 10.2.4: Assessment of missingness,        **
**  adherence, and other variables           **
***********************************************




Assessment of missingness in psyrats_voices_total between treated and untreated samples

N missing amongst treated samples
4/40

N missing at site 2
6/42

Fisher test for difference in proportion against null hypothesis that odds ratio is 1


	Fisher's Exact Test for Count Data

data:  cont_matrix_treatment
p-value = 0.7383
alternative hypothesis: true odds ratio is not equal to 1
95 percent confidence interval:
 0.1277858 3.1019442
sample estimates:
odds ratio 
 0.6699468 







Assessment of missingness in psyrats_voices_total between sites

N missing at site 1
2/39

N missing at site 2
8/43

Fisher test for difference in proportion against null hypothesis that odds ratio is 1


	Fisher's Exact Test for Count Data

data:  cont_matrix_site
p-value = 0.09193
alternative hypothesis: true odds ratio is not equal to 1
95 percent confidence interval:
 0.02333638 1.31995718
sample estimates:
odds ratio 
 0.2402927 







Assessment of difference in baseline psyrats_voices_total between missing and non-missing samples

Mean (SD) baseline psyrats_voices_total amongst non-missing samples
29.72 (5.03)

Mean baseline psyrats_voices_total amongst missing samples
28.4

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  pvt_missing and pvt_nonmissing
W = 296.5, p-value = 0.3704
alternative hypothesis: true location shift is not equal to 0







Assessment of difference in baseline HPSVQ_total between missing and non-missing samples

Mean (SD) baseline HPSVQ_total amongst non-missing samples
23.97 (5.872)

Mean baseline HPSVQ_total amongst missing samples
21.2

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  ht_missing and ht_nonmissing
W = 272.5, p-value = 0.2167
alternative hypothesis: true location shift is not equal to 0







***********************************************
** 10.2.4b: Repeat analysis 10.2.1 on        **
**  per-protocol population                  **
***********************************************


Estimated beta_2 (mean effect of treatment on PSYRATS voices total score at 8 weeks) in per-protocol population: 1.631 points;  95% CI: (-2.002, 5.256) points

All parameter estimates and 95% CIs (per-protocol): 

        Estimate CI95_lower CI95_upper                                      Description
σr       7.30800      5.919      8.766                SD of per-indivudal random effect
σe       6.32100      5.589      7.025                                  SD of residuals
β0      28.64000     25.840     31.450                                     Overall mean
βa2     -6.39300     -9.105     -3.673               Fixed effect for 8-week time point
βa3     -7.27800     -9.991     -4.560              Fixed effect for 12-week time point
β(site)  1.74800     -1.847      5.337                Fixed effect for site 2 vs site 1
β2       1.63100     -2.002      5.256  Fixed effect for treatment at 8-week time point
β3      -0.05288     -3.707      3.594 Fixed effect for treatment at 12-week time point


Parameter table saved to: ./Analysis/Results/Tables/PSYRATs_voices_total/parameter_table_psyrats_voices_total_perprotocol.csv




***********************************************
** 10.2.4c: Effect of COVID                  **
***********************************************




Difference in number of MUSE sessions for pre- and post-covid samples

Mean (SD) number of sessions for pre-covid samples
5.571 (0.5345)

Mean (SD) number of sessions for post-covid samples
5.296 (1.235)

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  nmuse[ind_precovid] and nmuse[ind_postcovid]
W = 109, p-value = 0.5339
alternative hypothesis: true location shift is not equal to 0







Difference in psyrats_voices_total for pre- and post-covid samples

Mean (SD) psyrats_voices_total for pre-covid samples
29.29 (6.195)

Mean (SD) psyrats_voices_total for post-covid samples
29.7 (4.801)

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  Y[ind_precovid] and Y[ind_postcovid]
W = 496.5, p-value = 0.6658
alternative hypothesis: true location shift is not equal to 0







Difference in psyrats_hdis for pre- and post-covid samples

Mean (SD) psyrats_hdis for pre-covid samples
14.64 (3.992)

Mean (SD) psyrats_hdis for post-covid samples
15.76 (2.909)

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  Y[ind_precovid] and Y[ind_postcovid]
W = 371.5, p-value = 0.2495
alternative hypothesis: true location shift is not equal to 0







Difference in hpsvq_total for pre- and post-covid samples

Mean (SD) hpsvq_total for pre-covid samples
22.29 (6.9)

Mean (SD) hpsvq_total for post-covid samples
24.14 (5.497)

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  Y[ind_precovid] and Y[ind_postcovid]
W = 402.5, p-value = 0.4541
alternative hypothesis: true location shift is not equal to 0







Difference in qpr_total for pre- and post-covid samples

Mean (SD) qpr_total for pre-covid samples
29.07 (9.833)

Mean (SD) qpr_total for post-covid samples
26.53 (11.07)

Wilcoxon rank-sum test against null hypothesis of equal medians


	Wilcoxon rank sum test with continuity correction

data:  Y[ind_precovid] and Y[ind_postcovid]
W = 500.5, p-value = 0.6301
alternative hypothesis: true location shift is not equal to 0







***********************************************
** 10.2.5: Mixed linear model analysis for   **
**  other outcomes, no covariates other than **
**  site                                     **
***********************************************


**** Analysis for outcome: psyrats_hdis ****

Estimated beta_2 (mean effect of treatment on outcome psyrats_hdis at 8 weeks) 0.5039 points;  95% CI: (-1.651, 2.653) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        4.0990     3.2900      4.942                SD of per-indivudal random effect
σe        3.7870     3.3490      4.209                                  SD of residuals
β0       14.7100    13.1100     16.320                                     Overall mean
βa2      -3.2470    -4.8640     -1.626               Fixed effect for 8-week time point
βa3      -3.6480    -5.2660     -2.029              Fixed effect for 12-week time point
β(site)   1.5910    -0.4554      3.635                Fixed effect for site 2 vs site 1
β2        0.5039    -1.6510      2.653  Fixed effect for treatment at 8-week time point
β3       -0.4278    -2.5940      1.735 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_psyrats_hdis.csv

*********************

**** Analysis for outcome: psyrats_delusions_total ****

Estimated beta_2 (mean effect of treatment on outcome psyrats_delusions_total at 8 weeks) -1.645 points;  95% CI: (-4.892, 1.613) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr         4.674      3.434     5.8760                SD of per-indivudal random effect
σe         6.056      5.353     6.7410                                  SD of residuals
β0        11.650      9.524    13.7800                                     Overall mean
βa2       -2.066     -4.591     0.4508               Fixed effect for 8-week time point
βa3       -4.435     -6.958    -1.9170              Fixed effect for 12-week time point
β(site)    4.407      1.820     6.9950                Fixed effect for site 2 vs site 1
β2        -1.645     -4.892     1.6130  Fixed effect for treatment at 8-week time point
β3        -0.932     -4.200     2.3440 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_psyrats_delusions_total.csv

*********************

**** Analysis for outcome: hpsvq_total ****

Estimated beta_2 (mean effect of treatment on outcome hpsvq_total at 8 weeks) 0.339 points;  95% CI: (-2.413, 3.092) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        6.2030    5.09400      7.384                SD of per-indivudal random effect
σe        4.6010    4.05700      5.123                                  SD of residuals
β0       22.1000   19.83000     24.380                                     Overall mean
βa2      -3.2830   -5.30600     -1.258               Fixed effect for 8-week time point
βa3      -5.4920   -7.51600     -3.469              Fixed effect for 12-week time point
β(site)   2.9210   -0.04991      5.885                Fixed effect for site 2 vs site 1
β2        0.3390   -2.41300      3.092  Fixed effect for treatment at 8-week time point
β3       -0.0629   -2.81400      2.692 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_hpsvq_total.csv

*********************

**** Analysis for outcome: hpsvq_negative ****

Estimated beta_2 (mean effect of treatment on outcome hpsvq_negative at 8 weeks) 0.2181 points;  95% CI: (-1.333, 1.764) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        3.2990     2.6910     3.9430                SD of per-indivudal random effect
σe        2.6090     2.3010     2.9060                                  SD of residuals
β0       10.2200     8.9900    11.4500                                     Overall mean
βa2      -1.9230    -3.0640    -0.7774               Fixed effect for 8-week time point
βa3      -2.6630    -3.8040    -1.5200              Fixed effect for 12-week time point
β(site)   1.3460    -0.2543     2.9400                Fixed effect for site 2 vs site 1
β2        0.2181    -1.3330     1.7640  Fixed effect for treatment at 8-week time point
β3       -0.6650    -2.2140     0.8807 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_hpsvq_negative.csv

*********************

**** Analysis for outcome: dass21_total ****

Estimated beta_2 (mean effect of treatment on outcome dass21_total at 8 weeks) -0.8171 points;  95% CI: (-5.578, 3.947) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       10.3500     8.4600     12.360                SD of per-indivudal random effect
σe        7.9990     7.0470      8.913                                  SD of residuals
β0       36.9600    33.1200     40.810                                     Overall mean
βa2      -5.6260    -9.1300     -2.116               Fixed effect for 8-week time point
βa3      -8.5360   -12.0400     -5.030              Fixed effect for 12-week time point
β(site)   5.2550     0.2562     10.250                Fixed effect for site 2 vs site 1
β2       -0.8171    -5.5780      3.947  Fixed effect for treatment at 8-week time point
β3       -1.8860    -6.7090      2.945 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_total.csv

*********************

**** Analysis for outcome: dass21_stress ****

Estimated beta_2 (mean effect of treatment on outcome dass21_stress at 8 weeks) -0.4725 points;  95% CI: (-2.391, 1.446) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        3.7560     3.0270     4.5190                SD of per-indivudal random effect
σe        3.2820     2.8920     3.6570                                  SD of residuals
β0       13.1700    11.7200    14.6200                                     Overall mean
βa2      -1.8850    -3.3090    -0.4575               Fixed effect for 8-week time point
βa3      -2.7990    -4.2240    -1.3730              Fixed effect for 12-week time point
β(site)   2.0500     0.1858     3.9060                Fixed effect for site 2 vs site 1
β2       -0.4725    -2.3910     1.4460  Fixed effect for treatment at 8-week time point
β3       -0.4263    -2.3710     1.5180 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_stress.csv

*********************

**** Analysis for outcome: dass21_anxiety ****

Estimated beta_2 (mean effect of treatment on outcome dass21_anxiety at 8 weeks) 0.03853 points;  95% CI: (-1.629, 1.707) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       3.65000     2.9770     4.3630                SD of per-indivudal random effect
σe       2.79800     2.4630     3.1200                                  SD of residuals
β0      10.44000     9.0830    11.7900                                     Overall mean
βa2     -1.67600    -2.9030    -0.4483               Fixed effect for 8-week time point
βa3     -2.79000    -4.0190    -1.5640              Fixed effect for 12-week time point
β(site)  2.16700     0.4112     3.9310                Fixed effect for site 2 vs site 1
β2       0.03853    -1.6290     1.7070  Fixed effect for treatment at 8-week time point
β3      -0.21390    -1.9030     1.4770 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_anxiety.csv

*********************

**** Analysis for outcome: dass21_depression ****

Estimated beta_2 (mean effect of treatment on outcome dass21_depression at 8 weeks) -0.3961 points;  95% CI: (-2.326, 1.536) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        4.5700      3.755     5.4390                SD of per-indivudal random effect
σe        3.1990      2.815     3.5680                                  SD of residuals
β0       13.3500     11.700    15.0100                                     Overall mean
βa2      -2.0540     -3.466    -0.6407               Fixed effect for 8-week time point
βa3      -2.9320     -4.345    -1.5200              Fixed effect for 12-week time point
β(site)   1.0480     -1.123     3.2140                Fixed effect for site 2 vs site 1
β2       -0.3961     -2.326     1.5360  Fixed effect for treatment at 8-week time point
β3       -1.2720     -3.226     0.6881 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_depression.csv

*********************

**** Analysis for outcome: eq5d_mobility ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_mobility at 8 weeks) -0.2398 points;  95% CI: (-0.6262, 0.1465) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       0.88560     0.7269     1.0550                SD of per-indivudal random effect
σe       0.63420     0.5575     0.7078                                  SD of residuals
β0       1.93600     1.6140     2.2580                                     Overall mean
βa2      0.14940    -0.1333     0.4321               Fixed effect for 8-week time point
βa3     -0.03215    -0.3148     0.2506              Fixed effect for 12-week time point
β(site) -0.13370    -0.5559     0.2887                Fixed effect for site 2 vs site 1
β2      -0.23980    -0.6262     0.1465  Fixed effect for treatment at 8-week time point
β3      -0.03548    -0.4244     0.3535 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_mobility.csv

*********************

**** Analysis for outcome: eq5d_self_care ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_self_care at 8 weeks) 0.09289 points;  95% CI: (-0.2645, 0.4503) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       0.77910     0.6326     0.9342                SD of per-indivudal random effect
σe       0.59130     0.5192     0.6610                                  SD of residuals
β0       1.67700     1.3880     1.9640                                     Overall mean
βa2     -0.01078    -0.2738     0.2514               Fixed effect for 8-week time point
βa3      0.04517    -0.2176     0.3075              Fixed effect for 12-week time point
β(site)  0.10470    -0.2698     0.4815                Fixed effect for site 2 vs site 1
β2       0.09289    -0.2645     0.4503  Fixed effect for treatment at 8-week time point
β3       0.11540    -0.2444     0.4752 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_self_care.csv

*********************

**** Analysis for outcome: eq5d_usual_activities ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_usual_activities at 8 weeks) -0.04919 points;  95% CI: (-0.5141, 0.417) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       0.78990     0.6140    0.96880                SD of per-indivudal random effect
σe       0.80540     0.7080    0.90010                                  SD of residuals
β0       2.57700     2.2540    2.90000                                     Overall mean
βa2     -0.22440    -0.5755    0.12440               Fixed effect for 8-week time point
βa3     -0.33400    -0.6847    0.01503              Fixed effect for 12-week time point
β(site)  0.01593    -0.3922    0.42370                Fixed effect for site 2 vs site 1
β2      -0.04919    -0.5141    0.41700  Fixed effect for treatment at 8-week time point
β3       0.09246    -0.3759    0.56140 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_usual_activities.csv

*********************

**** Analysis for outcome: eq5d_pain_discomfort ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_pain_discomfort at 8 weeks) 0.01347 points;  95% CI: (-0.3584, 0.3854) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       1.08200     0.9026     1.2760                SD of per-indivudal random effect
σe       0.59190     0.5198     0.6608                                  SD of residuals
β0       2.28500     1.9130     2.6570                                     Overall mean
βa2      0.01107    -0.2576     0.2789               Fixed effect for 8-week time point
βa3     -0.14280    -0.4116     0.1251              Fixed effect for 12-week time point
β(site)  0.24710    -0.2498     0.7446                Fixed effect for site 2 vs site 1
β2       0.01347    -0.3584     0.3854  Fixed effect for treatment at 8-week time point
β3       0.19230    -0.1818     0.5669 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_pain_discomfort.csv

*********************

**** Analysis for outcome: eq5d_anxiety_depression ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_anxiety_depression at 8 weeks) 0.0714 points;  95% CI: (-0.4004, 0.5435) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       0.83510     0.6582    1.01700                SD of per-indivudal random effect
σe       0.81040     0.7127    0.90490                                  SD of residuals
β0       3.46600     3.1320    3.80100                                     Overall mean
βa2     -0.12490    -0.4784    0.22780               Fixed effect for 8-week time point
βa3     -0.28510    -0.6389    0.06759              Fixed effect for 12-week time point
β(site) -0.05182    -0.4778    0.37290                Fixed effect for site 2 vs site 1
β2       0.07140    -0.4004    0.54350  Fixed effect for treatment at 8-week time point
β3       0.35220    -0.1229    0.82760 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_anxiety_depression.csv

*********************

**** Analysis for outcome: eq5d_health_today_vas ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_health_today_vas at 8 weeks) 13.01 points;  95% CI: (3.366, 22.6) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr       18.7900    15.1100     22.640                SD of per-indivudal random effect
σe       16.1600    14.2100     18.040                                  SD of residuals
β0       52.1500    44.9300     59.360                                     Overall mean
βa2      -3.5620   -10.6600      3.587               Fixed effect for 8-week time point
βa3       7.7680     0.6696     14.930              Fixed effect for 12-week time point
β(site)  -2.4710   -11.7600      6.819                Fixed effect for site 2 vs site 1
β2       13.0100     3.3660     22.600  Fixed effect for treatment at 8-week time point
β3       -0.9462   -10.6600      8.711 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_health_today_vas.csv

*********************

**** Analysis for outcome: qpr_total ****

Estimated beta_2 (mean effect of treatment on outcome qpr_total at 8 weeks) 2.297 points;  95% CI: (-1.989, 6.609) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr         8.698      7.040     10.440                SD of per-indivudal random effect
σe         7.177      6.315      8.007                                  SD of residuals
β0        27.750     24.450     31.040                                     Overall mean
βa2        4.938      1.756      8.100               Fixed effect for 8-week time point
βa3        4.783      1.641      7.909              Fixed effect for 12-week time point
β(site)   -1.166     -5.425      3.092                Fixed effect for site 2 vs site 1
β2         2.297     -1.989      6.609  Fixed effect for treatment at 8-week time point
β3         1.221     -3.066      5.531 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_qpr_total.csv

*********************

**** Analysis for outcome: choice_short_total ****

Estimated beta_2 (mean effect of treatment on outcome choice_short_total at 8 weeks) -4.645 points;  95% CI: (-12.85, 3.544) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        17.630     14.380    21.0900                SD of per-indivudal random effect
σe        13.200     11.560    14.7700                                  SD of residuals
β0        69.680     63.180    76.2000                                     Overall mean
βa2       -5.786    -12.000     0.4298               Fixed effect for 8-week time point
βa3       -7.255    -13.390    -1.1210              Fixed effect for 12-week time point
β(site)    3.253     -5.362    11.8400                Fixed effect for site 2 vs site 1
β2        -4.645    -12.850     3.5440  Fixed effect for treatment at 8-week time point
β3        -4.744    -13.100     3.6090 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_choice_short_total.csv

*********************

**** Analysis for outcome: sf36_pcs ****

Estimated beta_2 (mean effect of treatment on outcome sf36_pcs at 8 weeks) 2.361 points;  95% CI: (-1.431, 6.156) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr      14.41000     12.160     16.870                SD of per-indivudal random effect
σe       5.75800      5.047      6.433                                  SD of residuals
β0      37.94000     33.180     42.710                                     Overall mean
βa2     -1.74500     -4.467      0.978               Fixed effect for 8-week time point
βa3      0.02639     -2.663      2.718              Fixed effect for 12-week time point
β(site)  0.15970     -6.334      6.649                Fixed effect for site 2 vs site 1
β2       2.36100     -1.431      6.156  Fixed effect for treatment at 8-week time point
β3       0.89190     -2.879      4.661 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_sf36_pcs.csv

*********************

**** Analysis for outcome: sf36_mcs ****

Estimated beta_2 (mean effect of treatment on outcome sf36_mcs at 8 weeks) -0.4888 points;  95% CI: (-5.066, 4.086) points

All parameter estimates and 95% CIs: 

        Estimate CI95_lower CI95_upper                                      Description
σr        7.9830     6.3180     9.7050                SD of per-indivudal random effect
σe        7.6690     6.7370     8.5660                                  SD of residuals
β0       28.5100    25.3100    31.7100                                     Overall mean
βa2       5.1370     1.7020     8.5740               Fixed effect for 8-week time point
βa3       4.1500     0.7588     7.5530              Fixed effect for 12-week time point
β(site)  -3.2420    -7.3310     0.8528                Fixed effect for site 2 vs site 1
β2       -0.4888    -5.0660     4.0860  Fixed effect for treatment at 8-week time point
β3        3.4240    -1.1240     7.9660 Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_sf36_mcs.csv

*********************



***********************************************
** 10.2.5b: Draw figures                     **
***********************************************




Figure for changes at 8 weeks saved to: ./Analysis/Results/Figures/forest_plot_week_8.pdf



Figure for changes at 12 weeks saved to: ./Analysis/Results/Figures/forest_plot_week_12.pdf

Table for outcome: psyrats_voices_total: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "29.81 (4.452)"       
Week 8   "36"                                 "23.53 (12.89)"       
Week 12  "36"                                 "22.39 (11.65)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-6.75 (11.54)"                    "36"                                 
Week 12  "-7.444 (10.97)"                   "35"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "29.3 (5.553)"          "-"                                
Week 8   "24.56 (10.2)"          "-4.611 (7.695)"                   
Week 12  "21.91 (12.05)"         "-7.343 (9.315)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "-0.5095 (1.115)"          
Week 8   "72"                                      "1.028 (2.74)"             
Week 12  "71"                                      "-0.4746 (2.814)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "2.139 (-2.393, 6.67)"                 
Week 12  "0.1016 (-4.628, 4.831)"               


Parameter table saved to: ./Analysis/Results/Tables/PSYRATs_voices_total/difference_tablepsyrats_voices_total.csv

Table for outcome: psyrats_hdis: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "15.71 (2.752)"       
Week 8   "36"                                 "12.47 (6.984)"       
Week 12  "36"                                 "11.86 (6.673)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-3.444 (6.575)"                   "36"                                 
Week 12  "-3.722 (6.523)"                   "35"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "15.38 (3.439)"         "-"                                
Week 8   "12.61 (5.852)"         "-2.611 (4.073)"                   
Week 12  "11.2 (7.407)"          "-4 (5.851)"                       
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "-0.3393 (0.69)"           
Week 8   "72"                                      "0.1389 (1.519)"           
Week 12  "71"                                      "-0.6611 (1.675)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.8333 (-1.693, 3.36)"                
Week 12  "-0.2778 (-3.158, 2.603)"              


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_psyrats_hdis.csv

Table for outcome: psyrats_delusions_total: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "13.45 (7.369)"       
Week 8   "36"                                 "11.5 (8.749)"        
Week 12  "36"                                 "9.194 (8.318)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-1.889 (7.855)"                   "36"                                 
Week 12  "-4.278 (7.678)"                   "35"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "14.5 (7.024)"          "-"                                
Week 8   "10.42 (8.392)"         "-4.167 (9.352)"                   
Week 12  "8.6 (7.968)"           "-5.829 (9.448)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "1.048 (1.589)"            
Week 8   "72"                                      "-1.083 (2.02)"            
Week 12  "71"                                      "-0.5944 (1.933)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-2.278 (-6.267, 1.712)"               
Week 12  "-1.551 (-5.562, 2.46)"                


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_psyrats_delusions_total.csv

Table for outcome: hpsvq_total: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "23.64 (5.643)"       
Week 8   "35"                                 "20.49 (9.429)"       
Week 12  "35"                                 "17.94 (10.06)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-3.429 (8.071)"                   "34"                                 
Week 12  "-5.514 (8.521)"                   "34"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "23.62 (6.037)"         "-"                                
Week 8   "20.85 (7.824)"         "-3.147 (4.56)"                    
Week 12  "18.12 (8.714)"         "-5.735 (6.761)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "-0.01786 (1.292)"         
Week 8   "69"                                      "0.3672 (2.083)"           
Week 12  "69"                                      "0.1748 (2.264)"           
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.2815 (-2.8, 3.363)"                 
Week 12  "-0.221 (-3.845, 3.403)"               


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_hpsvq_total.csv

Table for outcome: hpsvq_negative: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "11.14 (3.19)"        
Week 8   "35"                                 "9.286 (4.7)"         
Week 12  "35"                                 "8.314 (5.155)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-2.114 (4.378)"                   "34"                                 
Week 12  "-2.743 (4.761)"                   "34"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "10.7 (3.757)"          "-"                                
Week 8   "9.059 (4.546)"         "-1.618 (3.055)"                   
Week 12  "7.382 (4.553)"         "-3.294 (3.697)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "-0.4429 (0.7714)"         
Week 8   "69"                                      "-0.2269 (1.113)"          
Week 12  "69"                                      "-0.9319 (1.17)"           
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.4966 (-1.28, 2.274)"                
Week 12  "-0.5513 (-2.559, 1.457)"              


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_hpsvq_negative.csv

Table for outcome: dass21_total: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "38.9 (11.62)"        
Week 8   "35"                                 "34.26 (15.39)"       
Week 12  "35"                                 "30.83 (15.03)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-6 (12.75)"                       "34"                                 
Week 12  "-8.771 (12.6)"                    "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "40.58 (10)"            "-"                                
Week 8   "33.5 (14.42)"          "-6.882 (10.85)"                   
Week 12  "29.5 (14.8)"           "-11.09 (12.51)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "1.67 (2.391)"             
Week 8   "69"                                      "-0.7571 (3.588)"          
Week 12  "67"                                      "-1.329 (3.647)"           
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.8824 (-6.463, 4.698)"              
Week 12  "-2.322 (-8.34, 3.695)"                


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_dass21_total.csv

Table for outcome: dass21_stress: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "14.1 (4.184)"        
Week 8   "35"                                 "12.46 (6.075)"       
Week 12  "35"                                 "11.43 (6.321)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-2.057 (5.023)"                   "34"                                 
Week 12  "-2.943 (5.116)"                   "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "14.4 (3.828)"          "-"                                
Week 8   "11.94 (5.009)"         "-2.5 (4.66)"                      
Week 12  "11 (5.465)"            "-3.438 (5.124)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.3048 (0.885)"           
Week 8   "69"                                      "-0.516 (1.339)"           
Week 12  "67"                                      "-0.4286 (1.441)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.4429 (-2.728, 1.842)"              
Week 12  "-0.4946 (-2.949, 1.96)"               


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_dass21_stress.csv

Table for outcome: dass21_anxiety: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "11.4 (4.418)"        
Week 8   "35"                                 "9.829 (5.02)"        
Week 12  "35"                                 "8.571 (4.448)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-1.714 (4.618)"                   "34"                                 
Week 12  "-2.829 (4.482)"                   "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "11.75 (4.199)"         "-"                                
Week 8   "9.912 (5.294)"         "-1.765 (3.358)"                   
Week 12  "8.5 (5.093)"           "-3.25 (3.844)"                    
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.3452 (0.9515)"          
Week 8   "69"                                      "0.08319 (1.243)"          
Week 12  "67"                                      "-0.07143 (1.173)"         
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.05042 (-1.952, 1.851)"             
Week 12  "-0.4214 (-2.416, 1.573)"              


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_dass21_anxiety.csv

Table for outcome: dass21_depression: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "13.4 (5.747)"        
Week 8   "35"                                 "11.97 (5.983)"       
Week 12  "35"                                 "10.83 (6.392)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-2.229 (4.353)"                   "34"                                 
Week 12  "-3 (5.145)"                       "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "14.42 (4.23)"          "-"                                
Week 8   "11.65 (5.672)"         "-2.618 (4.697)"                   
Week 12  "10 (5.668)"            "-4.406 (5.167)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "1.02 (1.111)"             
Week 8   "69"                                      "-0.3244 (1.403)"          
Week 12  "67"                                      "-0.8286 (1.474)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.3891 (-2.527, 1.749)"              
Week 12  "-1.406 (-3.878, 1.066)"               


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_dass21_depression.csv

Table for outcome: eq5d_mobility: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "1.786 (1.094)"       
Week 8   "34"                                 "2.029 (1.267)"       
Week 12  "34"                                 "1.853 (1.209)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "0.1176 (1.225)"                   "33"                                 
Week 12  "-0.02941 (0.9688)"                "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "1.95 (1.011)"          "-"                                
Week 8   "1.758 (1.062)"         "-0.09091 (0.6784)"                
Week 12  "1.812 (0.9311)"        "-0.09375 (0.6891)"                
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.1643 (0.2325)"          
Week 8   "67"                                      "-0.2718 (0.2852)"         
Week 12  "66"                                      "-0.04044 (0.2648)"        
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.2086 (-0.6809, 0.2638)"            
Week 12  "-0.06434 (-0.4681, 0.3394)"           


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_eq5d_mobility.csv

Table for outcome: eq5d_self_care: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "1.667 (0.8742)"      
Week 8   "34"                                 "1.676 (0.9119)"      
Week 12  "34"                                 "1.765 (1.156)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "0.05882 (0.6937)"                 "33"                                 
Week 12  "0.05882 (0.8507)"                 "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "1.8 (0.9923)"          "-"                                
Week 8   "1.758 (1.062)"         "0.1212 (0.8929)"                  
Week 12  "1.875 (0.7931)"        "0.1562 (0.9541)"                  
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.1333 (0.2069)"          
Week 8   "67"                                      "0.08111 (0.2421)"         
Week 12  "66"                                      "0.1103 (0.2429)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.06239 (-0.3213, 0.446)"             
Week 12  "0.09743 (-0.3397, 0.5345)"            


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_eq5d_self_care.csv

Table for outcome: eq5d_usual_activities: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "2.595 (1.061)"       
Week 8   "34"                                 "2.294 (1.001)"       
Week 12  "34"                                 "2.206 (1.2)"         
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-0.1176 (1.094)"                  "33"                                 
Week 12  "-0.2647 (0.9942)"                 "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "2.575 (1.196)"         "-"                                
Week 8   "2.303 (1.212)"         "-0.2424 (1.251)"                  
Week 12  "2.312 (1.061)"         "-0.2188 (1.289)"                  
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "-0.02024 (0.2501)"        
Week 8   "67"                                      "0.008913 (0.2719)"        
Week 12  "66"                                      "0.1066 (0.2785)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.1248 (-0.6882, 0.4386)"            
Week 12  "0.04596 (-0.5117, 0.6036)"            


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_eq5d_usual_activities.csv

Table for outcome: eq5d_pain_discomfort: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "2.405 (1.17)"        
Week 8   "34"                                 "2.353 (1.203)"       
Week 12  "34"                                 "2.176 (1.167)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "0.02941 (0.7972)"                 "33"                                 
Week 12  "-0.08824 (0.83)"                  "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "2.425 (1.238)"         "-"                                
Week 8   "2.364 (1.295)"         "0.0303 (0.8095)"                  
Week 12  "2.438 (1.413)"         "0.03125 (0.9995)"                 
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.02024 (0.2663)"         
Week 8   "67"                                      "0.0107 (0.3056)"          
Week 12  "66"                                      "0.261 (0.32)"             
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.0008913 (-0.3839, 0.3857)"          
Week 12  "0.1195 (-0.3252, 0.5642)"             


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_eq5d_pain_discomfort.csv

Table for outcome: eq5d_anxiety_depression: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "3.429 (1.151)"       
Week 8   "34"                                 "3.294 (1.06)"        
Week 12  "34"                                 "3.118 (1.225)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-0.1176 (1.094)"                  "33"                                 
Week 12  "-0.2647 (1.163)"                  "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "3.45 (1.108)"          "-"                                
Week 8   "3.364 (1.22)"          "-0.09091 (1.208)"                 
Week 12  "3.469 (1.244)"         "0.125 (1.212)"                    
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.02143 (0.2495)"         
Week 8   "67"                                      "0.06952 (0.2795)"         
Week 12  "66"                                      "0.3511 (0.3041)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.02674 (-0.5258, 0.5793)"            
Week 12  "0.3897 (-0.1838, 0.9633)"             


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_eq5d_anxiety_depression.csv

Table for outcome: eq5d_health_today_vas: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "54.81 (23.75)"       
Week 8   "34"                                 "49.24 (27.73)"       
Week 12  "34"                                 "61.15 (25.99)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-4.941 (18.74)"                   "33"                                 
Week 12  "5.5 (19.18)"                      "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "46.7 (22.7)"           "-"                                
Week 8   "59.03 (23.67)"         "10 (26.35)"                       
Week 12  "56.84 (25.27)"         "7.062 (27.82)"                    
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "-8.11 (5.129)"            
Week 8   "67"                                      "9.795 (6.292)"            
Week 12  "66"                                      "-4.303 (6.31)"            
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "14.94 (3.962, 25.92)"                 
Week 12  "1.562 (-10.03, 13.16)"                


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_eq5d_health_today_vas.csv

Table for outcome: qpr_total: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "42"                                 "26.88 (12.39)"       
Week 8   "34"                                 "31 (11.76)"          
Week 12  "35"                                 "31.29 (13.05)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "5.765 (10.02)"                    "33"                                 
Week 12  "5.229 (12.45)"                    "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "27.4 (9.473)"          "-"                                
Week 8   "35.15 (9.351)"         "6.697 (8.064)"                    
Week 12  "33.94 (11.78)"         "5.594 (11.19)"                    
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "82"                                      "0.519 (2.428)"            
Week 8   "67"                                      "4.152 (2.592)"            
Week 12  "67"                                      "2.652 (3.034)"            
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "0.9323 (-3.417, 5.282)"               
Week 12  "0.3652 (-5.295, 6.026)"               


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_qpr_total.csv

Table for outcome: choice_short_total: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "40"                                 "71.15 (19.84)"       
Week 8   "30"                                 "65.93 (23.46)"       
Week 12  "31"                                 "64 (25.25)"          
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-6.833 (12.54)"                   "34"                                 
Week 12  "-7.129 (19.8)"                    "30"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "71.55 (19.77)"         "-"                                
Week 8   "59.85 (23.54)"         "-10.09 (17.77)"                   
Week 12  "59.77 (23.81)"         "-11.33 (23.58)"                   
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "80"                                      "0.4 (4.428)"              
Week 8   "64"                                      "-6.08 (5.886)"            
Week 12  "61"                                      "-4.233 (6.282)"           
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-3.255 (-10.73, 4.216)"               
Week 12  "-4.204 (-15.15, 6.739)"               


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_choice_short_total.csv

Table for outcome: sf36_pcs: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "41"                                 "38.16 (13.61)"       
Week 8   "32"                                 "36.51 (17.09)"       
Week 12  "33"                                 "38.38 (15.89)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "-1.991 (8.988)"                   "32"                                 
Week 12  "-0.04868 (7.323)"                 "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "37.89 (15.94)"         "-"                                
Week 8   "39.25 (16.84)"         "0.2359 (7.627)"                   
Week 12  "38.45 (17.59)"         "1.072 (10.83)"                    
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "81"                                      "-0.2705 (3.298)"          
Week 8   "64"                                      "2.743 (4.242)"            
Week 12  "65"                                      "0.06603 (4.161)"          
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "2.226 (-1.858, 6.311)"                
Week 12  "1.12 (-3.387, 5.628)"                 


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_sf36_pcs.csv

Table for outcome: sf36_mcs: 

         TAU: number of usable outcome scores TAU: outcome mean (SD)
Baseline "41"                                 "27.45 (10.52)"       
Week 8   "32"                                 "32.08 (12.64)"       
Week 12  "33"                                 "31.61 (12.19)"       
         TAU: change from baseline (95% CI) MUSE: number of usable outcome scores
Baseline "-"                                "40"                                 
Week 8   "5.467 (10.49)"                    "32"                                 
Week 12  "3.854 (12.05)"                    "32"                                 
         MUSE: outcome mean (SD) MUSE: change from baseline (95% CI)
Baseline "26.2 (9.34)"           "-"                                
Week 8   "31.41 (10.34)"         "4.816 (10.47)"                    
Week 12  "34.64 (12.9)"          "7.165 (11.85)"                    
         MUSE-TAU: number of usable outcome scores MUSE-TAU: outcome mean (SD)
Baseline "81"                                      "-1.252 (2.209)"           
Week 8   "64"                                      "-0.6699 (2.887)"          
Week 12  "65"                                      "3.03 (3.116)"             
         MUSE-TAU: change from baseline (95% CI)
Baseline "-"                                    
Week 8   "-0.6505 (-5.786, 4.485)"              
Week 12  "3.31 (-2.5, 9.121)"                   


Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/differences_table_sf36_mcs.csv



***********************************************
** 10.2.6: Mixed linear model analysis for   **
**  other outcomes, covariates included      **
***********************************************


**** Analysis for outcome: psyrats_hdis, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome psyrats_hdis at 8 weeks) -0.165 points;  95% CI: (-2.346, 1.966) points

All parameter estimates and 95% CIs: 

             Estimate CI95_lower CI95_upper
σr            3.77700   2.772000    4.38500
σe            3.66400   3.216000    4.08800
β0            7.90800   3.000000   12.80000
βa2          -2.60400  -4.243000   -0.93770
βa3          -3.56300  -5.209000   -1.91100
β(site)       0.67810  -1.461000    2.81900
β(age)        0.07652  -0.025530    0.17860
β(sex_M)     -0.77470  -2.800000    1.25100
β(mod_total)  1.25000   0.056320    2.44600
β(base_dur)   0.00178  -0.007787    0.01135
β(time_eng)   0.02968  -0.072600    0.13210
β(delusions)  0.13810  -0.017430    0.29410
β2           -0.16500  -2.346000    1.96600
β3           -0.36230  -2.545000    1.78700
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_psyrats_hdis_covariates.csv

*********************

**** Analysis for outcome: psyrats_delusions_total, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome psyrats_delusions_total at 8 weeks) -2.027 points;  95% CI: (-5.268, 1.207) points

All parameter estimates and 95% CIs: 

               Estimate CI95_lower CI95_upper
σr            4.0720000    2.48100    5.00700
σe            5.8720000    5.15700    6.57200
β0            7.6130000    1.59100   13.66000
βa2          -1.7700000   -4.33400    0.80840
βa3          -4.4160000   -6.96400   -1.83000
β(site)       3.5080000    0.85720    6.15900
β(age)        0.0490800   -0.07744    0.17510
β(sex_M)     -2.7010000   -5.23000   -0.18720
β(mod_total)  1.6730000    0.31590    3.03300
β(base_dur)   0.0008856   -0.01131    0.01294
β(time_eng)   0.0837300   -0.04289    0.21010
β2           -2.0270000   -5.26800    1.20700
β3           -1.6730000   -4.94500    1.56400
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_psyrats_delusions_total_covariates.csv

*********************

**** Analysis for outcome: hpsvq_total, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome hpsvq_total at 8 weeks) 0.4385 points;  95% CI: (-2.357, 3.221) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            5.482000    4.13900    6.30700
σe            4.571000    4.00500    5.10500
β0           13.530000    6.64900   20.38000
βa2          -3.343000   -5.41700   -1.24800
βa3          -5.128000   -7.20900   -3.04600
β(site)       1.052000   -1.94300    4.05600
β(age)        0.044190   -0.09859    0.18730
β(sex_M)     -3.005000   -5.84800   -0.16250
β(mod_total)  1.917000    0.23900    3.59300
β(base_dur)   0.002011   -0.01132    0.01533
β(time_eng)   0.068430   -0.07531    0.21220
β(delusions)  0.315800    0.09751    0.53480
β2            0.438500   -2.35700    3.22100
β3           -0.334500   -3.12000    2.45100
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_hpsvq_total_covariates.csv

*********************

**** Analysis for outcome: hpsvq_negative, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome hpsvq_negative at 8 weeks) 0.4582 points;  95% CI: (-1.13, 1.998) points

All parameter estimates and 95% CIs: 

               Estimate CI95_lower CI95_upper
σr            3.0070000   2.257000   3.465000
σe            2.5680000   2.250000   2.869000
β0            5.3560000   1.564000   9.136000
βa2          -2.0910000  -3.245000  -0.904100
βa3          -2.5510000  -3.711000  -1.375000
β(site)       0.4284000  -1.222000   2.085000
β(age)        0.0481000  -0.030590   0.127000
β(sex_M)     -1.5300000  -3.098000   0.036190
β(mod_total)  1.0700000   0.146100   1.995000
β(base_dur)   0.0005136  -0.006849   0.007859
β(time_eng)   0.0256400  -0.053550   0.104900
β(delusions)  0.1367000   0.016250   0.257300
β2            0.4582000  -1.130000   1.998000
β3           -0.6826000  -2.262000   0.859800
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_hpsvq_negative_covariates.csv

*********************

**** Analysis for outcome: dass21_total, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome dass21_total at 8 weeks) -0.1357 points;  95% CI: (-4.755, 4.475) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            8.788000    6.58700    10.1400
σe            7.593000    6.64700     8.4870
β0           24.880000   13.74000    36.0200
βa2          -6.042000   -9.49500    -2.5900
βa3          -8.793000  -12.25000    -5.3560
β(site)       0.483600   -4.36400     5.3330
β(age)        0.068790   -0.16240     0.2998
β(sex_M)     -6.200000  -10.82000    -1.5840
β(mod_total)  5.571000    2.85800     8.2950
β(base_dur)   0.003823   -0.01781     0.0254
β(time_eng)   0.003995   -0.22820     0.2363
β(delusions)  0.205000   -0.14890     0.5584
β2           -0.135700   -4.75500     4.4750
β3           -1.625000   -6.29600     3.0560
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_total_covariates.csv

*********************

**** Analysis for outcome: dass21_stress, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome dass21_stress at 8 weeks) -0.268 points;  95% CI: (-2.168, 1.614) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            3.327000   2.448000    3.85900
σe            3.157000   2.764000    3.52700
β0           10.340000   6.019000   14.65000
βa2          -2.037000  -3.456000   -0.60560
βa3          -2.853000  -4.272000   -1.42600
β(site)       0.365100  -1.510000    2.24400
β(age)       -0.027890  -0.117400    0.06166
β(sex_M)     -1.712000  -3.503000    0.07536
β(mod_total)  1.820000   0.768600    2.87600
β(base_dur)   0.004772  -0.003658    0.01315
β(time_eng)  -0.006010  -0.095800    0.08382
β(delusions)  0.071020  -0.066270    0.20790
β2           -0.268000  -2.168000    1.61400
β3           -0.383300  -2.310000    1.52200
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_stress_covariates.csv

*********************

**** Analysis for outcome: dass21_anxiety, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome dass21_anxiety at 8 weeks) 0.3666 points;  95% CI: (-1.26, 2.006) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            3.168000    2.37500   3.652000
σe            2.677000    2.34300   2.995000
β0            7.054000    3.05800  11.050000
βa2          -1.867000   -3.09200  -0.652300
βa3          -2.742000   -3.96800  -1.531000
β(site)       0.474900   -1.26500   2.213000
β(age)        0.036550   -0.04625   0.119500
β(sex_M)     -2.846000   -4.50100  -1.191000
β(mod_total)  1.780000    0.80410   2.753000
β(base_dur)  -0.002886   -0.01060   0.004888
β(time_eng)  -0.009609   -0.09289   0.073730
β(delusions)  0.068910   -0.05774   0.195800
β2            0.366600   -1.26000   2.006000
β3           -0.186700   -1.83500   1.474000
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_anxiety_covariates.csv

*********************

**** Analysis for outcome: dass21_depression, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome dass21_depression at 8 weeks) -0.2441 points;  95% CI: (-2.183, 1.69) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            4.143000   3.155000    4.75000
σe            3.123000   2.732000    3.49500
β0            7.487000   2.387000   12.58000
βa2          -2.128000  -3.563000   -0.69370
βa3          -3.175000  -4.616000   -1.74900
β(site)      -0.345900  -2.569000    1.87700
β(age)        0.061120  -0.044870    0.16680
β(sex_M)     -1.652000  -3.765000    0.46170
β(mod_total)  1.957000   0.715800    3.20600
β(base_dur)   0.001996  -0.007878    0.01181
β(time_eng)   0.019400  -0.087200    0.12610
β(delusions)  0.065210  -0.096850    0.22690
β2           -0.244100  -2.183000    1.69000
β3           -1.089000  -3.044000    0.88050
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_dass21_depression_covariates.csv

*********************

**** Analysis for outcome: eq5d_mobility, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_mobility at 8 weeks) -0.1294 points;  95% CI: (-0.5257, 0.2704) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            0.788500   0.591700  0.9081000
σe            0.639500   0.558600  0.7172000
β0            0.633700  -0.353800  1.6160000
βa2           0.044470  -0.252900  0.3389000
βa3          -0.055730  -0.352900  0.2383000
β(site)      -0.011100  -0.440400  0.4188000
β(age)        0.037450   0.017030  0.0579100
β(sex_M)     -0.374500  -0.782500  0.0344200
β(mod_total) -0.079870  -0.321000  0.1603000
β(base_dur)  -0.001394  -0.003294  0.0005185
β(time_eng)   0.013610  -0.006940  0.0342200
β(delusions)  0.038010   0.006847  0.0694500
β2           -0.129400  -0.525700  0.2704000
β3           -0.032580  -0.429600  0.3713000
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_mobility_covariates.csv

*********************

**** Analysis for outcome: eq5d_self_care, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_self_care at 8 weeks) 0.08257 points;  95% CI: (-0.2968, 0.4636) points

All parameter estimates and 95% CIs: 

               Estimate CI95_lower CI95_upper
σr            0.7332000  0.5424000    0.84720
σe            0.6133000  0.5356000    0.68930
β0            0.9312000  0.0090320    1.85100
βa2          -0.0309100 -0.3183000    0.24890
βa3           0.0356400 -0.2494000    0.31670
β(site)       0.1131000 -0.2895000    0.51400
β(age)        0.0181700 -0.0009232    0.03730
β(sex_M)     -0.4243000 -0.8055000   -0.04137
β(mod_total)  0.0032300 -0.2220000    0.22810
β(base_dur)  -0.0002439 -0.0020220    0.00155
β(time_eng)   0.0120000 -0.0072040    0.03126
β(delusions)  0.0265000 -0.0027290    0.05575
β2            0.0825700 -0.2968000    0.46360
β3            0.1035000 -0.2778000    0.48680
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_self_care_covariates.csv

*********************

**** Analysis for outcome: eq5d_usual_activities, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_usual_activities at 8 weeks) -0.1565 points;  95% CI: (-0.6389, 0.3303) points

All parameter estimates and 95% CIs: 

               Estimate CI95_lower CI95_upper
σr            0.6603000  0.4133000   0.792800
σe            0.8350000  0.7298000   0.940500
β0            0.6415000 -0.2994000   1.577000
βa2          -0.1265000 -0.5048000   0.242900
βa3          -0.2814000 -0.6574000   0.088640
β(site)       0.0373800 -0.3701000   0.444100
β(age)        0.0325900  0.0132200   0.052030
β(sex_M)      0.0125100 -0.3770000   0.401100
β(mod_total)  0.1317000 -0.0968600   0.362100
β(base_dur)   0.0009138 -0.0009446   0.002751
β(time_eng)   0.0131100 -0.0062630   0.032510
β(delusions)  0.0292400 -0.0004766   0.059040
β2           -0.1565000 -0.6389000   0.330300
β3            0.0354500 -0.4515000   0.522200
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_usual_activities_covariates.csv

*********************

**** Analysis for outcome: eq5d_pain_discomfort, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_pain_discomfort at 8 weeks) 0.01444 points;  95% CI: (-0.3556, 0.3857) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            1.008000   0.786200   1.146000
σe            0.569500   0.497100   0.639300
β0            0.966100  -0.220800   2.152000
βa2           0.009919  -0.262700   0.277100
βa3          -0.155400  -0.427600   0.111800
β(site)       0.189200  -0.330100   0.708100
β(age)        0.037720   0.013090   0.062410
β(sex_M)     -0.638700  -1.131000  -0.147200
β(mod_total)  0.180700  -0.109200   0.470300
β(base_dur)  -0.000129  -0.002400   0.002141
β(time_eng)   0.016420  -0.008527   0.041400
β(delusions) -0.001406  -0.039060   0.036290
β2            0.014440  -0.355600   0.385700
β3            0.275700  -0.095690   0.650100
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_pain_discomfort_covariates.csv

*********************

**** Analysis for outcome: eq5d_anxiety_depression, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_anxiety_depression at 8 weeks) -0.02553 points;  95% CI: (-0.5029, 0.462) points

All parameter estimates and 95% CIs: 

               Estimate CI95_lower CI95_upper
σr            0.7481000   0.526300   0.878500
σe            0.8103000   0.708400   0.907400
β0            2.1680000   1.160000   3.177000
βa2          -0.0497300  -0.421700   0.312000
βa3          -0.2207000  -0.592700   0.140200
β(site)      -0.1887000  -0.627900   0.249800
β(age)        0.0079320  -0.013000   0.028810
β(sex_M)     -0.0508700  -0.470100   0.367100
β(mod_total)  0.3627000   0.116200   0.609500
β(base_dur)   0.0002821  -0.001695   0.002253
β(time_eng)   0.0027740  -0.018150   0.023730
β(delusions)  0.0149200  -0.017060   0.047000
β2           -0.0255300  -0.502900   0.462000
β3            0.3052000  -0.175200   0.794400
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_anxiety_depression_covariates.csv

*********************

**** Analysis for outcome: eq5d_health_today_vas, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome eq5d_health_today_vas at 8 weeks) 13.58 points;  95% CI: (3.532, 23.45) points

All parameter estimates and 95% CIs: 

             Estimate CI95_lower CI95_upper
σr           16.00000   11.33000   18.74000
σe           16.61000   14.52000   18.62000
β0           85.40000   64.15000  106.70000
βa2          -3.52000  -11.00000    4.07800
βa3           8.32300    0.86960   15.94000
β(site)      -3.25500  -12.51000    6.00800
β(age)       -0.60490   -1.04600   -0.16340
β(sex_M)      1.78400   -7.03600   10.62000
β(mod_total) -2.97500   -8.19600    2.21400
β(base_dur)  -0.01787   -0.05937    0.02378
β(time_eng)  -0.02171   -0.46500    0.41960
β(delusions) -0.54330   -1.21900    0.13200
β2           13.58000    3.53200   23.45000
β3           -0.89480  -11.00000    9.01700
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_eq5d_health_today_vas_covariates.csv

*********************

**** Analysis for outcome: qpr_total, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome qpr_total at 8 weeks) 1.936 points;  95% CI: (-2.386, 6.425) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            7.102000    5.07700   8.305000
σe            7.324000    6.40600   8.200000
β0           39.460000   30.03000  48.900000
βa2           5.326000    1.96300   8.619000
βa3           5.069000    1.76700   8.330000
β(site)      -0.900500   -5.00100   3.210000
β(age)       -0.193300   -0.38840   0.002688
β(sex_M)      4.080000    0.17120   7.991000
β(mod_total) -1.911000   -4.22300   0.386800
β(base_dur)   0.006509   -0.01192   0.024920
β(time_eng)   0.098080   -0.09815   0.293900
β(delusions) -0.402100   -0.70220  -0.103100
β2            1.936000   -2.38600   6.425000
β3            1.293000   -3.03200   5.758000
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_qpr_total_covariates.csv

*********************

**** Analysis for outcome: choice_short_total, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome choice_short_total at 8 weeks) -4.465 points;  95% CI: (-12.89, 3.697) points

All parameter estimates and 95% CIs: 

             Estimate CI95_lower CI95_upper
σr            14.3800   10.41000   16.73000
σe            13.1600   11.44000   14.81000
β0            46.4900   27.83000   65.12000
βa2           -6.2240  -12.62000    0.22780
βa3           -5.6180  -11.92000    0.72250
β(site)       -0.3004   -8.60700    8.02000
β(age)         0.1364   -0.25040    0.52170
β(sex_M)      -7.6980  -15.51000    0.08681
β(mod_total)   5.9440    1.35600   10.55000
β(base_dur)    0.0157   -0.02025    0.05153
β(time_eng)   -0.1619   -0.55090    0.22710
β(delusions)   0.8264    0.23580    1.42100
β2            -4.4650  -12.89000    3.69700
β3            -6.6190  -15.12000    1.76500
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_choice_short_total_covariates.csv

*********************

**** Analysis for outcome: sf36_pcs, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome sf36_pcs at 8 weeks) 1.527 points;  95% CI: (-2.341, 5.419) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr           12.610000    9.98700 14.2500000
σe            5.706000    4.96900  6.4030000
β0           64.030000   49.44000 78.6500000
βa2          -0.629600   -3.44500  2.1870000
βa3           0.290100   -2.48700  3.0700000
β(site)      -0.442600   -6.90900  6.0270000
β(age)       -0.650800   -0.95420 -0.3475000
β(sex_M)      7.032000    0.96560 13.1000000
β(mod_total) -1.985000   -5.56200  1.5940000
β(base_dur)   0.005545   -0.02212  0.0331800
β(time_eng)  -0.306400   -0.61310  0.0001564
β(delusions) -0.220300   -0.68640  0.2446000
β2            1.527000   -2.34100  5.4190000
β3            0.851200   -3.00300  4.6960000
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_sf36_pcs_covariates.csv

*********************

**** Analysis for outcome: sf36_mcs, covariates included ****

Estimated beta_2 (mean effect of treatment on outcome sf36_mcs at 8 weeks) -0.3613 points;  95% CI: (-5.09, 4.367) points

All parameter estimates and 95% CIs: 

              Estimate CI95_lower CI95_upper
σr            7.203000    5.06600    8.46000
σe            7.736000    6.74800    8.67100
β0           33.230000   23.47000   42.98000
βa2           4.760000    1.17300    8.38200
βa3           4.613000    1.09700    8.20700
β(site)      -1.291000   -5.58500    3.00000
β(age)        0.043920   -0.15780    0.24620
β(sex_M)      1.451000   -2.60600    5.50900
β(mod_total) -3.295000   -5.71300   -0.89850
β(base_dur)  -0.004645   -0.02354    0.01437
β(time_eng)   0.135500   -0.06573    0.33670
β(delusions) -0.090990   -0.40220    0.22200
β2           -0.361300   -5.09000    4.36700
β3            3.239000   -1.44800    7.90700
                                                                                Description
σr                                                        SD of per-indivudal random effect
σe                                                                          SD of residuals
β0                                                                             Overall mean
βa2                                                      Fixed effect for 8-week time point
βa3                                                     Fixed effect for 12-week time point
β(site)                                                   Fixed effect for site 2 vs site 1
β(age)                                                                 Fixed effect for age
β(sex_M)                                                        Fixed effect for sex M vs F
β(mod_total) Fixed effect for number of hallucinatory modalities, excluding sensed presence
β(base_dur)                                  Fixed effect for baseline duration of symptoms
β(time_eng)                              Fixed effect for length of time engaged in service
β(delusions)                      Fixed effect for PSYRATs total delusion score at baseline
β2                                          Fixed effect for treatment at 8-week time point
β3                                         Fixed effect for treatment at 12-week time point

Parameter table saved to: ./Analysis/Results/Tables/Other_outcomes/parameter_table_sf36_mcs_covariates.csv

*********************



***********************************************
** 10.2.7: Assessment of potential primary   **
**  outcomes                                 **
***********************************************


Adherence to potential primary outcomes: number of missing values

                        Baseline 8week 12week
psyrats_voices_total           0    10     11
psyrats_hdis                   0    10     11
psyrats_delusions_total        0    10     11
hpsvq_total                    0    13     13
hpsvq_negative                 0    13     13
dass21_total                   0    13     15
dass21_stress                  0    13     15
dass21_anxiety                 0    13     15
dass21_depression              0    13     15
eq5d_mobility                  0    15     16
eq5d_self_care                 0    15     16
eq5d_usual_activities          0    15     16
eq5d_pain_discomfort           0    15     16
eq5d_anxiety_depression        0    15     16
eq5d_health_today_vas          0    15     16
qpr_total                      0    15     15
choice_short_total             2    18     21
sf36_pcs                       1    18     17
sf36_mcs                       1    18     17

Table saved to: ./Analysis/Results/Tables/Comparison/adherence.csv


Spearman (rank) correlation between potential primary outcomes at time baseline: 

                        psyrats_voices_total psyrats_hdis psyrats_delusions_total hpsvq_total
psyrats_voices_total               1.0000000    0.6567686              0.39148265   0.6496436
psyrats_hdis                       0.6567686    1.0000000              0.26996528   0.4833730
psyrats_delusions_total            0.3914827    0.2699653              1.00000000   0.4356873
hpsvq_total                        0.6496436    0.4833730              0.43568734   1.0000000
hpsvq_negative                     0.6098291    0.6490135              0.39901682   0.8873746
dass21_total                       0.5334991    0.4721738              0.32020355   0.6090742
dass21_stress                      0.4061976    0.3495278              0.27811766   0.5719807
dass21_anxiety                     0.4144942    0.3286466              0.18613988   0.4815932
dass21_depression                  0.4593945    0.4379064              0.29528823   0.4657833
eq5d_mobility                      0.2376361    0.2126757              0.06803698   0.1823480
eq5d_self_care                     0.1522756    0.1001396              0.18386258   0.1445232
eq5d_usual_activities              0.2883215    0.1528107              0.17669797   0.1991812
eq5d_pain_discomfort               0.1396760    0.1817701              0.00933934   0.1130435
eq5d_anxiety_depression            0.3014855    0.2240770              0.17367022   0.2991054
eq5d_health_today_vas             -0.2754850   -0.2989551             -0.33215631  -0.1657914
qpr_total                         -0.3359903   -0.3443006             -0.21111601  -0.3154321
choice_short_total                 0.3305091    0.2745866              0.37558515   0.3533104
sf36_pcs                          -0.2436521   -0.1514561             -0.10707506  -0.1104557
sf36_mcs                          -0.2386100   -0.3548308             -0.19294399  -0.2733558
                        hpsvq_negative dass21_total dass21_stress dass21_anxiety dass21_depression
psyrats_voices_total         0.6098291    0.5334991    0.40619762     0.41449417         0.4593945
psyrats_hdis                 0.6490135    0.4721738    0.34952784     0.32864658         0.4379064
psyrats_delusions_total      0.3990168    0.3202036    0.27811766     0.18613988         0.2952882
hpsvq_total                  0.8873746    0.6090742    0.57198071     0.48159319         0.4657833
hpsvq_negative               1.0000000    0.5363697    0.49643722     0.38637990         0.4315664
dass21_total                 0.5363697    1.0000000    0.79416736     0.77311706         0.8371952
dass21_stress                0.4964372    0.7941674    1.00000000     0.46003518         0.5424430
dass21_anxiety               0.3863799    0.7731171    0.46003518     1.00000000         0.4559478
dass21_depression            0.4315664    0.8371952    0.54244300     0.45594779         1.0000000
eq5d_mobility                0.2483158    0.2330160    0.09334706     0.26453089         0.1420837
eq5d_self_care               0.1666098    0.1875640    0.07437498     0.24164995         0.1186928
eq5d_usual_activities        0.2144715    0.2027076    0.18885631     0.05857559         0.2627080
eq5d_pain_discomfort         0.1464260    0.2604320    0.18338104     0.25288881         0.1362444
eq5d_anxiety_depression      0.2925145    0.3297886    0.24514816     0.18468436         0.3541150
eq5d_health_today_vas       -0.1757822   -0.2942943   -0.17839514    -0.16497502        -0.3524028
qpr_total                   -0.3241212   -0.5187174   -0.36556626    -0.27060375        -0.5884259
choice_short_total           0.3606987    0.5602523    0.45373164     0.33753935         0.5612483
sf36_pcs                    -0.1298271   -0.3170462   -0.16648841    -0.34382857        -0.2185416
sf36_mcs                    -0.2999484   -0.4349480   -0.28478042    -0.20499258        -0.5463993
                        eq5d_mobility eq5d_self_care eq5d_usual_activities eq5d_pain_discomfort
psyrats_voices_total       0.23763609     0.15227559            0.28832152           0.13967597
psyrats_hdis               0.21267567     0.10013958            0.15281068           0.18177013
psyrats_delusions_total    0.06803698     0.18386258            0.17669797           0.00933934
hpsvq_total                0.18234800     0.14452321            0.19918116           0.11304346
hpsvq_negative             0.24831581     0.16660984            0.21447154           0.14642603
dass21_total               0.23301595     0.18756401            0.20270759           0.26043204
dass21_stress              0.09334706     0.07437498            0.18885631           0.18338104
dass21_anxiety             0.26453089     0.24164995            0.05857559           0.25288881
dass21_depression          0.14208366     0.11869283            0.26270803           0.13624442
eq5d_mobility              1.00000000     0.47414458            0.35436434           0.61463139
eq5d_self_care             0.47414458     1.00000000            0.43765010           0.42946231
eq5d_usual_activities      0.35436434     0.43765010            1.00000000           0.41718175
eq5d_pain_discomfort       0.61463139     0.42946231            0.41718175           1.00000000
eq5d_anxiety_depression    0.13159101     0.16495070            0.48681248           0.35360698
eq5d_health_today_vas     -0.29218619    -0.21741103           -0.39893085          -0.34679300
qpr_total                 -0.20035327    -0.22749792           -0.39679155          -0.19477439
choice_short_total         0.10989798     0.10335647            0.22768839           0.09649485
sf36_pcs                  -0.60967765    -0.49032918           -0.38869155          -0.71101149
sf36_mcs                   0.08984374     0.06269350           -0.20915152           0.05812434
                        eq5d_anxiety_depression eq5d_health_today_vas  qpr_total choice_short_total
psyrats_voices_total                  0.3014855            -0.2754850 -0.3359903         0.33050915
psyrats_hdis                          0.2240770            -0.2989551 -0.3443006         0.27458660
psyrats_delusions_total               0.1736702            -0.3321563 -0.2111160         0.37558515
hpsvq_total                           0.2991054            -0.1657914 -0.3154321         0.35331043
hpsvq_negative                        0.2925145            -0.1757822 -0.3241212         0.36069869
dass21_total                          0.3297886            -0.2942943 -0.5187174         0.56025228
dass21_stress                         0.2451482            -0.1783951 -0.3655663         0.45373164
dass21_anxiety                        0.1846844            -0.1649750 -0.2706038         0.33753935
dass21_depression                     0.3541150            -0.3524028 -0.5884259         0.56124831
eq5d_mobility                         0.1315910            -0.2921862 -0.2003533         0.10989798
eq5d_self_care                        0.1649507            -0.2174110 -0.2274979         0.10335647
eq5d_usual_activities                 0.4868125            -0.3989308 -0.3967915         0.22768839
eq5d_pain_discomfort                  0.3536070            -0.3467930 -0.1947744         0.09649485
eq5d_anxiety_depression               1.0000000            -0.4256825 -0.3640068         0.36302187
eq5d_health_today_vas                -0.4256825             1.0000000  0.4706912        -0.38444193
qpr_total                            -0.3640068             0.4706912  1.0000000        -0.71990687
choice_short_total                    0.3630219            -0.3844419 -0.7199069         1.00000000
sf36_pcs                             -0.1715634             0.4238603  0.2617147        -0.15444324
sf36_mcs                             -0.4716444             0.3244281  0.5442342        -0.46758595
                          sf36_pcs    sf36_mcs
psyrats_voices_total    -0.2436521 -0.23861002
psyrats_hdis            -0.1514561 -0.35483083
psyrats_delusions_total -0.1070751 -0.19294399
hpsvq_total             -0.1104557 -0.27335582
hpsvq_negative          -0.1298271 -0.29994842
dass21_total            -0.3170462 -0.43494801
dass21_stress           -0.1664884 -0.28478042
dass21_anxiety          -0.3438286 -0.20499258
dass21_depression       -0.2185416 -0.54639931
eq5d_mobility           -0.6096777  0.08984374
eq5d_self_care          -0.4903292  0.06269350
eq5d_usual_activities   -0.3886916 -0.20915152
eq5d_pain_discomfort    -0.7110115  0.05812434
eq5d_anxiety_depression -0.1715634 -0.47164439
eq5d_health_today_vas    0.4238603  0.32442813
qpr_total                0.2617147  0.54423423
choice_short_total      -0.1544432 -0.46758595
sf36_pcs                 1.0000000 -0.23337850
sf36_mcs                -0.2333785  1.00000000

Table saved to: ./Analysis/Results/Tables/Comparison/correlation_baseline.csv


Spearman (rank) correlation between potential primary outcomes at time 8weeks: 

                        psyrats_voices_total psyrats_hdis psyrats_delusions_total hpsvq_total
psyrats_voices_total              1.00000000   0.87825427              0.48455651   0.8270036
psyrats_hdis                      0.87825427   1.00000000              0.46483535   0.7880304
psyrats_delusions_total           0.48455651   0.46483535              1.00000000   0.5001137
hpsvq_total                       0.82700361   0.78803040              0.50011368   1.0000000
hpsvq_negative                    0.79362897   0.76964820              0.44863986   0.9351852
dass21_total                      0.47280187   0.52997393              0.55722332   0.6222925
dass21_stress                     0.43828936   0.50680076              0.56598478   0.5571650
dass21_anxiety                    0.38883428   0.36492194              0.48454461   0.5473066
dass21_depression                 0.47504084   0.55657532              0.42015473   0.5832676
eq5d_mobility                     0.20158385   0.03381599              0.17473518   0.1617573
eq5d_self_care                    0.13357945   0.03409550              0.06747914   0.1004409
eq5d_usual_activities             0.42580017   0.31078874              0.34764026   0.3806758
eq5d_pain_discomfort              0.23857933   0.16853047              0.21135112   0.2359299
eq5d_anxiety_depression           0.23003038   0.30519343              0.29246293   0.3653183
eq5d_health_today_vas            -0.19783419  -0.22629714             -0.25692893  -0.2498371
qpr_total                        -0.43156926  -0.40117335             -0.42391452  -0.4534592
choice_short_total                0.40281859   0.42892422              0.44866245   0.4645463
sf36_pcs                         -0.08711173   0.05008200             -0.15077604  -0.1118659
sf36_mcs                         -0.45129068  -0.48808650             -0.47686269  -0.4782520
                        hpsvq_negative dass21_total dass21_stress dass21_anxiety dass21_depression
psyrats_voices_total         0.7936290    0.4728019    0.43828936      0.3888343        0.47504084
psyrats_hdis                 0.7696482    0.5299739    0.50680076      0.3649219        0.55657532
psyrats_delusions_total      0.4486399    0.5572233    0.56598478      0.4845446        0.42015473
hpsvq_total                  0.9351852    0.6222925    0.55716496      0.5473066        0.58326763
hpsvq_negative               1.0000000    0.6442818    0.56025798      0.5559939        0.63346806
dass21_total                 0.6442818    1.0000000    0.92343332      0.8828090        0.87627245
dass21_stress                0.5602580    0.9234333    1.00000000      0.7705563        0.70765681
dass21_anxiety               0.5559939    0.8828090    0.77055626      1.0000000        0.64647877
dass21_depression            0.6334681    0.8762724    0.70765681      0.6464788        1.00000000
eq5d_mobility                0.2202507    0.1696396    0.12091535      0.2725146        0.07311579
eq5d_self_care               0.1467864    0.1167360    0.07793583      0.1091535        0.14035206
eq5d_usual_activities        0.3726088    0.4478926    0.36891920      0.3631516        0.43020898
eq5d_pain_discomfort         0.2815278    0.3582470    0.29326086      0.4405829        0.25583211
eq5d_anxiety_depression      0.3506994    0.4436779    0.36489259      0.2992207        0.51928395
eq5d_health_today_vas       -0.2372538   -0.3869354   -0.33724640     -0.2645486       -0.43213482
qpr_total                   -0.4419401   -0.4854013   -0.41010858     -0.3566347       -0.52961742
choice_short_total           0.4663499    0.5066513    0.46889458      0.4040304        0.50600679
sf36_pcs                    -0.1746001   -0.2888630   -0.22210818     -0.3983118       -0.15771575
sf36_mcs                    -0.5279122   -0.6906319   -0.64068697     -0.5122398       -0.71671669
                        eq5d_mobility eq5d_self_care eq5d_usual_activities eq5d_pain_discomfort
psyrats_voices_total       0.20158385     0.13357945             0.4258002           0.23857933
psyrats_hdis               0.03381599     0.03409550             0.3107887           0.16853047
psyrats_delusions_total    0.17473518     0.06747914             0.3476403           0.21135112
hpsvq_total                0.16175730     0.10044091             0.3806758           0.23592993
hpsvq_negative             0.22025069     0.14678639             0.3726088           0.28152778
dass21_total               0.16963957     0.11673603             0.4478926           0.35824696
dass21_stress              0.12091535     0.07793583             0.3689192           0.29326086
dass21_anxiety             0.27251462     0.10915352             0.3631516           0.44058291
dass21_depression          0.07311579     0.14035206             0.4302090           0.25583211
eq5d_mobility              1.00000000     0.53735975             0.4990518           0.65556086
eq5d_self_care             0.53735975     1.00000000             0.5448590           0.44161142
eq5d_usual_activities      0.49905184     0.54485905             1.0000000           0.41848361
eq5d_pain_discomfort       0.65556086     0.44161142             0.4184836           1.00000000
eq5d_anxiety_depression    0.14396096     0.17268022             0.3725402           0.09369957
eq5d_health_today_vas     -0.38488670    -0.45511992            -0.5634731          -0.40626108
qpr_total                 -0.28512879    -0.26094767            -0.5007622          -0.29979961
choice_short_total         0.17320643     0.05727904             0.2759806           0.13861780
sf36_pcs                  -0.80890288    -0.48458003            -0.5009515          -0.78680558
sf36_mcs                  -0.02568946    -0.14177568            -0.3951180          -0.07908308
                        eq5d_anxiety_depression eq5d_health_today_vas  qpr_total choice_short_total
psyrats_voices_total                 0.23003038            -0.1978342 -0.4315693         0.40281859
psyrats_hdis                         0.30519343            -0.2262971 -0.4011733         0.42892422
psyrats_delusions_total              0.29246293            -0.2569289 -0.4239145         0.44866245
hpsvq_total                          0.36531830            -0.2498371 -0.4534592         0.46454634
hpsvq_negative                       0.35069940            -0.2372538 -0.4419401         0.46634992
dass21_total                         0.44367793            -0.3869354 -0.4854013         0.50665129
dass21_stress                        0.36489259            -0.3372464 -0.4101086         0.46889458
dass21_anxiety                       0.29922072            -0.2645486 -0.3566347         0.40403040
dass21_depression                    0.51928395            -0.4321348 -0.5296174         0.50600679
eq5d_mobility                        0.14396096            -0.3848867 -0.2851288         0.17320643
eq5d_self_care                       0.17268022            -0.4551199 -0.2609477         0.05727904
eq5d_usual_activities                0.37254024            -0.5634731 -0.5007622         0.27598056
eq5d_pain_discomfort                 0.09369957            -0.4062611 -0.2997996         0.13861780
eq5d_anxiety_depression              1.00000000            -0.4379011 -0.4206137         0.42942635
eq5d_health_today_vas               -0.43790110             1.0000000  0.5566126        -0.32021473
qpr_total                           -0.42061369             0.5566126  1.0000000        -0.78684957
choice_short_total                   0.42942635            -0.3202147 -0.7868496         1.00000000
sf36_pcs                            -0.09735773             0.4410536  0.3028756        -0.15503388
sf36_mcs                            -0.51270332             0.3393303  0.5526896        -0.57013679
                           sf36_pcs    sf36_mcs
psyrats_voices_total    -0.08711173 -0.45129068
psyrats_hdis             0.05008200 -0.48808650
psyrats_delusions_total -0.15077604 -0.47686269
hpsvq_total             -0.11186590 -0.47825196
hpsvq_negative          -0.17460015 -0.52791219
dass21_total            -0.28886301 -0.69063186
dass21_stress           -0.22210818 -0.64068697
dass21_anxiety          -0.39831181 -0.51223983
dass21_depression       -0.15771575 -0.71671669
eq5d_mobility           -0.80890288 -0.02568946
eq5d_self_care          -0.48458003 -0.14177568
eq5d_usual_activities   -0.50095150 -0.39511802
eq5d_pain_discomfort    -0.78680558 -0.07908308
eq5d_anxiety_depression -0.09735773 -0.51270332
eq5d_health_today_vas    0.44105358  0.33933026
qpr_total                0.30287563  0.55268957
choice_short_total      -0.15503388 -0.57013679
sf36_pcs                 1.00000000 -0.04766484
sf36_mcs                -0.04766484  1.00000000

Table saved to: ./Analysis/Results/Tables/Comparison/correlation_8weeks.csv


Spearman (rank) correlation between potential primary outcomes at time 12weeks: 

                        psyrats_voices_total psyrats_hdis psyrats_delusions_total hpsvq_total
psyrats_voices_total              1.00000000  0.904185516              0.32031553  0.86561626
psyrats_hdis                      0.90418552  1.000000000              0.26378590  0.79680201
psyrats_delusions_total           0.32031553  0.263785903              1.00000000  0.39134286
hpsvq_total                       0.86561626  0.796802008              0.39134286  1.00000000
hpsvq_negative                    0.81887316  0.784778581              0.34141843  0.92440701
dass21_total                      0.54173612  0.526931357              0.31482580  0.61087690
dass21_stress                     0.49623421  0.474220208              0.25356697  0.55058116
dass21_anxiety                    0.33324671  0.312036171              0.25758354  0.43217172
dass21_depression                 0.55430778  0.563806922              0.33938551  0.61091350
eq5d_mobility                     0.17440888  0.149742705              0.03610147  0.11451422
eq5d_self_care                    0.09830082  0.063876870              0.06471472  0.12495070
eq5d_usual_activities             0.19879370  0.212179588              0.05959631  0.13777292
eq5d_pain_discomfort              0.05188237  0.095373034              0.12635090  0.01384555
eq5d_anxiety_depression           0.42564510  0.395235193              0.04571862  0.39356230
eq5d_health_today_vas            -0.17298621 -0.181518245             -0.14580656 -0.24798754
qpr_total                        -0.53740376 -0.560482427             -0.26964574 -0.57380489
choice_short_total                0.50586384  0.460466221              0.54042906  0.55776386
sf36_pcs                         -0.01010771 -0.002485233             -0.05896411  0.03524538
sf36_mcs                         -0.42053334 -0.431616810             -0.23416848 -0.50029166
                        hpsvq_negative dass21_total dass21_stress dass21_anxiety dass21_depression
psyrats_voices_total        0.81887316    0.5417361     0.4962342      0.3332467         0.5543078
psyrats_hdis                0.78477858    0.5269314     0.4742202      0.3120362         0.5638069
psyrats_delusions_total     0.34141843    0.3148258     0.2535670      0.2575835         0.3393855
hpsvq_total                 0.92440701    0.6108769     0.5505812      0.4321717         0.6109135
hpsvq_negative              1.00000000    0.6816144     0.6030393      0.5125541         0.6853854
dass21_total                0.68161442    1.0000000     0.9178257      0.8319773         0.8967722
dass21_stress               0.60303929    0.9178257     1.0000000      0.6690974         0.7447024
dass21_anxiety              0.51255412    0.8319773     0.6690974      1.0000000         0.6331986
dass21_depression           0.68538543    0.8967722     0.7447024      0.6331986         1.0000000
eq5d_mobility               0.17250498    0.2113509     0.2020422      0.1927709         0.1466476
eq5d_self_care              0.21544248    0.3036671     0.2428918      0.3336753         0.2583074
eq5d_usual_activities       0.25366288    0.4498222     0.3973080      0.3937542         0.4123700
eq5d_pain_discomfort        0.17306296    0.2759930     0.1907788      0.3492718         0.2500848
eq5d_anxiety_depression     0.45673490    0.5856001     0.5112667      0.4155020         0.6086037
eq5d_health_today_vas      -0.35602115   -0.4283801    -0.4010077     -0.2449690        -0.4836455
qpr_total                  -0.63690753   -0.6431989    -0.6084392     -0.3629920        -0.7354758
choice_short_total          0.55658180    0.7483529     0.6769234      0.5974361         0.7394535
sf36_pcs                   -0.07867374   -0.1965260    -0.1518536     -0.2403300        -0.1622543
sf36_mcs                   -0.57684568   -0.6674319    -0.6361909     -0.4337047        -0.7239357
                        eq5d_mobility eq5d_self_care eq5d_usual_activities eq5d_pain_discomfort
psyrats_voices_total       0.17440888     0.09830082            0.19879370           0.05188237
psyrats_hdis               0.14974271     0.06387687            0.21217959           0.09537303
psyrats_delusions_total    0.03610147     0.06471472            0.05959631           0.12635090
hpsvq_total                0.11451422     0.12495070            0.13777292           0.01384555
hpsvq_negative             0.17250498     0.21544248            0.25366288           0.17306296
dass21_total               0.21135086     0.30366707            0.44982217           0.27599303
dass21_stress              0.20204223     0.24289177            0.39730801           0.19077878
dass21_anxiety             0.19277088     0.33367534            0.39375420           0.34927179
dass21_depression          0.14664755     0.25830737            0.41236999           0.25008483
eq5d_mobility              1.00000000     0.57873115            0.61277161           0.59310117
eq5d_self_care             0.57873115     1.00000000            0.69780144           0.54021290
eq5d_usual_activities      0.61277161     0.69780144            1.00000000           0.50437082
eq5d_pain_discomfort       0.59310117     0.54021290            0.50437082           1.00000000
eq5d_anxiety_depression    0.16758781     0.31833662            0.39440579           0.30761405
eq5d_health_today_vas     -0.43857049    -0.48804694           -0.52595587          -0.41026513
qpr_total                 -0.23046734    -0.30127321           -0.43124480          -0.15013527
choice_short_total         0.21327269     0.26876107            0.39726784           0.17077892
sf36_pcs                  -0.66442199    -0.56946407           -0.57564252          -0.81267591
sf36_mcs                  -0.06234912    -0.09385603           -0.26789622          -0.07253284
                        eq5d_anxiety_depression eq5d_health_today_vas  qpr_total choice_short_total
psyrats_voices_total                 0.42564510            -0.1729862 -0.5374038          0.5058638
psyrats_hdis                         0.39523519            -0.1815182 -0.5604824          0.4604662
psyrats_delusions_total              0.04571862            -0.1458066 -0.2696457          0.5404291
hpsvq_total                          0.39356230            -0.2479875 -0.5738049          0.5577639
hpsvq_negative                       0.45673490            -0.3560211 -0.6369075          0.5565818
dass21_total                         0.58560005            -0.4283801 -0.6431989          0.7483529
dass21_stress                        0.51126674            -0.4010077 -0.6084392          0.6769234
dass21_anxiety                       0.41550200            -0.2449690 -0.3629920          0.5974361
dass21_depression                    0.60860372            -0.4836455 -0.7354758          0.7394535
eq5d_mobility                        0.16758781            -0.4385705 -0.2304673          0.2132727
eq5d_self_care                       0.31833662            -0.4880469 -0.3012732          0.2687611
eq5d_usual_activities                0.39440579            -0.5259559 -0.4312448          0.3972678
eq5d_pain_discomfort                 0.30761405            -0.4102651 -0.1501353          0.1707789
eq5d_anxiety_depression              1.00000000            -0.3948005 -0.4930141          0.5147753
eq5d_health_today_vas               -0.39480046             1.0000000  0.5411292         -0.5218095
qpr_total                           -0.49301409             0.5411292  1.0000000         -0.7346975
choice_short_total                   0.51477526            -0.5218095 -0.7346975          1.0000000
sf36_pcs                            -0.18756558             0.5011214  0.1508754         -0.0790838
sf36_mcs                            -0.56698612             0.4648289  0.7627089         -0.7096911
                            sf36_pcs    sf36_mcs
psyrats_voices_total    -0.010107710 -0.42053334
psyrats_hdis            -0.002485233 -0.43161681
psyrats_delusions_total -0.058964107 -0.23416848
hpsvq_total              0.035245382 -0.50029166
hpsvq_negative          -0.078673738 -0.57684568
dass21_total            -0.196525998 -0.66743194
dass21_stress           -0.151853617 -0.63619088
dass21_anxiety          -0.240329965 -0.43370471
dass21_depression       -0.162254270 -0.72393567
eq5d_mobility           -0.664421989 -0.06234912
eq5d_self_care          -0.569464071 -0.09385603
eq5d_usual_activities   -0.575642517 -0.26789622
eq5d_pain_discomfort    -0.812675907 -0.07253284
eq5d_anxiety_depression -0.187565575 -0.56698612
eq5d_health_today_vas    0.501121380  0.46482889
qpr_total                0.150875353  0.76270892
choice_short_total      -0.079083796 -0.70969111
sf36_pcs                 1.000000000 -0.01547203
sf36_mcs                -0.015472028  1.00000000

Table saved to: ./Analysis/Results/Tables/Comparison/correlation_12weeks.csv




***********************************************
** Main analysis complete                    **
***********************************************





Checking empirical cover of confidence intervals



Confidence interval cover (nominally 95%) and quantile in Bin(n,0.95):

         cover   quantile
sigma_r 0.9585 0.96661262
sigma_e 0.9495 0.47342906
beta_0  0.9545 0.83502757
beta_a2 0.9455 0.19052827
beta_a3 0.9425 0.07070548
beta_2  0.9520 0.67346223
beta_3  0.9505 0.55520041
beta    0.9535 0.77734739
